Heart-Sparing Radiotherapy Shows Early Survival Gains in Lung Cancer Treatment

The RAPID-RT study, presented at ESTRO 2025, demonstrates the feasibility and modest 12-month survival improvement of a new cardiac dose-limiting technique for stage I–III lung cancer patients.